[go: up one dir, main page]

MX2010006044A - Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion. - Google Patents

Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.

Info

Publication number
MX2010006044A
MX2010006044A MX2010006044A MX2010006044A MX2010006044A MX 2010006044 A MX2010006044 A MX 2010006044A MX 2010006044 A MX2010006044 A MX 2010006044A MX 2010006044 A MX2010006044 A MX 2010006044A MX 2010006044 A MX2010006044 A MX 2010006044A
Authority
MX
Mexico
Prior art keywords
fragment
solution phase
solid
different
coupled
Prior art date
Application number
MX2010006044A
Other languages
English (en)
Inventor
Yeun-Kwei Han
Li Chen
Christopher R Roberts
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2010006044A publication Critical patent/MX2010006044A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención refiere a la preparación de péptidos insulinotrópicos que se sintetizan utilizando una técnica en fase sólida y en solución ("híbrida") Generalmente la técnica incluye la síntesis de tres fragmentos intermediarios de péptido diferentes utilizando la química en fase sólida. Luego se utiliza la química en fase de solución para añadir material aminoácido adicional al tercer fragmento que entonces se acopla al segundo fragmento y luego al primer fragmento en solución. Alternativamente, un segundo fragmento diferente se acopla al primer fragmento en la fase sólida. Luego, se utiliza la química en fase de solución para añadir material aminoácido adicional a un tercer fragmento diferente. A continuación, este tercer fragmento diferente se acopla al primero acoplado y al segundo fragmento diferente en la fase de solución. La utilización de una pseudoprolina en uno de los fragmentos facilita la síntesis en fase sólida de ese fragmento y también facilita el subsiguiente acoplamiento en fase de solución de este fragmento a otros fragmentos. La presente invención es muy útil en la obtención de péptidos insulinotrópicos tal como el GLP-1 (7-36) y sus homólogos naturales y no naturales.
MX2010006044A 2007-12-11 2008-12-02 Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion. MX2010006044A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US723807P 2007-12-11 2007-12-11
PCT/EP2008/066585 WO2009074483A2 (en) 2007-12-11 2008-12-02 Insulinotropic peptide synthesis using solid and solution phase combination techniques

Publications (1)

Publication Number Publication Date
MX2010006044A true MX2010006044A (es) 2010-06-23

Family

ID=40755926

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006044A MX2010006044A (es) 2007-12-11 2008-12-02 Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.

Country Status (17)

Country Link
US (1) US8227571B2 (es)
EP (1) EP2222695A2 (es)
JP (1) JP2011506376A (es)
KR (1) KR20100102652A (es)
CN (1) CN101903400B (es)
AR (1) AR069608A1 (es)
AU (1) AU2008334783A1 (es)
BR (1) BRPI0820765A2 (es)
CA (1) CA2707132A1 (es)
CL (1) CL2008003660A1 (es)
IL (1) IL205932A0 (es)
MX (1) MX2010006044A (es)
PE (1) PE20091214A1 (es)
RU (1) RU2010128247A (es)
TW (1) TWI374890B (es)
WO (1) WO2009074483A2 (es)
ZA (1) ZA201003849B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010054326A2 (en) * 2008-11-07 2010-05-14 The General Hospital Corporation C-terminal fragments of glucagon-like peptide-1 (glp-1)
CN102414220A (zh) * 2009-05-01 2012-04-11 霍夫曼-拉罗奇有限公司 使用固相和液相组合技术的促胰岛素肽合成
US20110313131A1 (en) 2010-06-21 2011-12-22 Christelle Carl Reversed phase hplc purification of a glp-1 analogue
US20120157382A1 (en) 2010-12-21 2012-06-21 Siegfried Krimmer Pharmaceutical glp-1 compositions having an improved release profile
ES2777502T3 (es) 2011-04-05 2020-08-05 Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung Ev Novedosos péptidos y su uso en diagnóstico y tratamiento
WO2013006692A2 (en) 2011-07-06 2013-01-10 The General Hospital Corporation Methods of treatment using a pentapeptide derived from the c-terminus of glucagon-like peptide 1 (glp-1)
WO2014077801A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification process for preparing highly pure taspoglutide
WO2014077802A1 (en) 2012-11-13 2014-05-22 Ipsen Pharma S.A.S. Purification method of a glp-1 analogue
JP2016505640A (ja) 2013-01-28 2016-02-25 ソレイ リミテッド ライアビリティ カンパニー 満腹ホルモン放出活性を有する新規なポリペプチド
EP2976325B1 (en) 2013-03-21 2017-03-01 Sanofi-Aventis Deutschland GmbH Synthesis of cyclic imide containing peptide products
HK1219477A1 (zh) 2013-03-21 2017-04-07 Sanofi-Aventis Deutschland Gmbh 合成含有乙内酰脲的肽产物
GR20140100479A (el) * 2014-09-23 2016-05-05 Novetide, Ltd., Συνθεση λιραγλουτιδης
WO2019069274A1 (en) * 2017-10-04 2019-04-11 Chemical & Biopharmaceutical Laboratories Of Patras S.A. PROCESS FOR THE PREPARATION OF A GLUCAGON-LIKE PEPTIDE
KR20200001546A (ko) * 2018-06-27 2020-01-06 주식회사 시선바이오머티리얼스 Pna 올리고머의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9909018A (pt) * 1998-03-23 2001-10-16 Trimeris Inc Processo para a sìntese de um peptìdeo, conjunto de fragmentos de peptìdeo, e, peptìdeo
KR20050037004A (ko) * 1998-12-07 2005-04-20 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. Glp-1의 유사체
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
CN1918177A (zh) * 2003-12-18 2007-02-21 诺和诺德公司 新型glp-1化合物
EP1709071A4 (en) * 2004-01-08 2007-05-30 Theratechnologies Inc GLUCAGON LIKE PEPTIDE-1 ANALOGS WITH LONG PERFORMANCE
CN101133078B (zh) * 2004-12-30 2011-07-27 弗·哈夫曼-拉罗切有限公司 使用肽中间片段合成肽t-20
ATE439371T1 (de) * 2004-12-30 2009-08-15 Hoffmann La Roche Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten
ES2332418T3 (es) * 2004-12-30 2010-02-04 F. Hoffmann-La Roche Ag Sintesis del peptido t-20 empleando fragmentos intermedios del peptido.
EP1891106A2 (en) * 2005-05-05 2008-02-27 Cadila Healthcare Ltd. Novel compounds as glp-i agonists
DE602007014184D1 (de) * 2006-02-08 2011-06-09 Lonza Ag Synthese von glucagon-ähnlichen peptiden
AU2007263043B2 (en) * 2006-06-23 2012-11-29 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成

Also Published As

Publication number Publication date
IL205932A0 (en) 2010-11-30
WO2009074483A3 (en) 2010-05-14
KR20100102652A (ko) 2010-09-24
EP2222695A2 (en) 2010-09-01
AU2008334783A1 (en) 2009-06-18
AR069608A1 (es) 2010-02-03
WO2009074483A2 (en) 2009-06-18
US20090292108A1 (en) 2009-11-26
RU2010128247A (ru) 2012-01-20
CN101903400B (zh) 2013-12-18
TW200927756A (en) 2009-07-01
CA2707132A1 (en) 2009-06-18
JP2011506376A (ja) 2011-03-03
BRPI0820765A2 (pt) 2015-06-16
ZA201003849B (en) 2011-04-28
PE20091214A1 (es) 2009-08-14
CL2008003660A1 (es) 2010-01-04
US8227571B2 (en) 2012-07-24
TWI374890B (en) 2012-10-21
CN101903400A (zh) 2010-12-01

Similar Documents

Publication Publication Date Title
UA96602C2 (ru) Способ получения инсулинотропных пептидов
MX2010006044A (es) Sintesis de peptidos insulinotropicos utilizando una combinacion de tecnicas en fase solida y en solucion.
WO2010125079A3 (en) Insulinotropic peptide synthesis using solid and solution phase combination techniques
GEP20146112B (en) Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and usage thereof
TR201816260T4 (tr) Wt1-antijen peptid konjugat aşı.
WO2009018126A3 (en) Collagen-related peptides and uses thereof
WO2007002261A3 (en) IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
WO2001034635A3 (en) Methods and compositions for peptide synthesis
WO2005116051A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
IL196478B (en) Humanized antibodies and their fragments that bind amyloid beta and nucleic acids, vectors and cells that produce them, as well as compound mixtures and their relevant therapeutic uses
WO2006024275A3 (de) Erfindung betreffend glp-1 und exendin
WO2007120834A3 (en) Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
WO2007115571A8 (en) Erbb receptor-derived peptide fragments
PT1987052E (pt) Síntese de péptidos tipo glucagina
WO2010115995A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
WO2005000086A3 (en) FRAGMENTS OF NKp44 AND NKp46 FOR TARGETING VIRAL-INFECTED AND TUMOR CELLS
WO2012027555A3 (en) Glycated cd59 peptides, their preparation, and uses thereof
IL184080A0 (en) Synthesis of peptide t-20 using peptide intermediate fragments
MX2009012085A (es) Métodos para la expansión dirigida de epítopes para el uso como ligandos de anticuerpos.
IL184081A0 (en) Synthesis using peptide intermediate fragments iii
MX2009008754A (es) Anticuerpos novedosos contra igf-1r.
WO2007100358A3 (en) Convergent synthesis of proteins by kinetically controlled ligation
TH112508A (th) การสังเคราะห์เปปไทด์ที่ออกฤทธิ์กระตุ้นอินซูลินโดยใช้เทคนิคการรวมกันของวัฏภาคของแข็งและสารละลาย
TH107349A (th) การสังเคราะห์อินซูลิโนโทรพิค เปปไทด์
ATE439371T1 (de) Synthese von peptid t-1249 mit peptidzwischenproduktfragmenten

Legal Events

Date Code Title Description
FG Grant or registration